Market Cap: $4.48M
EL
Evogene Ltd.
EVGN
NASDAQ (NASDAQ Global Market)USD
Market Cap: $4.48M
Evogene Ltd (Ticker: EVGN) focuses on leveraging its proprietary AI technology to enhance its operations and product offerings. In its recent financial results for the first quarter of 2026, the compa…
Evogene Ltd. (Ticker: EVGN) is positioning itself prominently within the biotechnology and pharmaceutical landscapes through its participation in the upcoming BIO International Convention in San Diego…
Evogene Ltd. (Ticker: EVGN) announces a significant advancement in its clinical research with the successful completion of a Phase 1 study for BMC128, a microbiome therapy developed by its subsidiary,…
Evogene Showcases AI-Driven Innovations at BIO-Europe Spring 2026 Conference Evogene Ltd., a leader in computational chemistry, prepares to showcase its cutting-edge advancements in AI-driven small-mo…
Evogene Showcases AI-Driven Innovations at BIO-Europe Spring 2026 Conference Evogene Ltd. announces its participation in the highly anticipated BIO-Europe Spring 2026 conference, running from March 23…
Evogene Shows Promising Growth in Q4 Driven by Innovative Agtech Solutions Evogene, a biotechnology company specializing in agricultural solutions, reports a noteworthy growth trajectory in its Q4 ear…
Evogene: Pioneering Innovations in Sustainable Agriculture In its recent Q4 earnings announcement, Evogene (NASDAQ:EVGN) showcases its growth in the biotechnological solutions sector, particularly aim…
Evogene Advances Agricultural Biotechnology Solutions Amidst Growth Trajectory Evogene (NASDAQ:EVGN) announces a promising outlook in its recent Q4 earnings report, underscoring its evolution within t…
Evogene's Strategic Shift: Harnessing AI for Health and Agriculture In a recent Letter to Shareholders, Evogene Ltd. CEO Ofer Haviv outlines a significant strategic transformation that positions the c…
Evogene’s Strategic Shift: Harnessing Computational Chemistry for Future Growth Evogene Ltd., a computational chemistry innovator based in Rehovot, Israel, is undergoing a transformative change aimed…
Evogene Reorients Strategy to Harness ChemPass AI™ for Health and Agriculture Evogene Ltd., a computational chemistry innovator headquartered in Rehovot, Israel, undertakes a strategic transformation…
Evogene secures near-term funding via warrant inducement Evogene Ltd. is securing immediate cash through a warrant inducement agreement with an existing institutional investor, strengthening its near-…
Evogene enlists leaders to sharpen AI-driven molecule discovery Strengthening ChemPass AI with academic heavyweights Evogene Ltd. appoints Prof. John J. Irwin of UCSF and Prof. Dan T. Major of Bar‑Ila…
Evogene taps UCSF and Bar‑Ilan scientists to strengthen AI-driven molecule design SAB additions aim to accelerate ChemPass AI for drug and ag‑chemical discovery Evogene appoints Prof. John J. Irwin of…
Evogene adds high-profile scientific advisers to sharpen its AI discovery engine Evogene Ltd., the Rehovot, Israel–based computational chemistry company, is strengthening scientific leadership of its…
Strategic Partnership Pioneers Remyelination Therapies for Multiple Sclerosis Evogene Ltd. and Unravel Biosciences, Inc. forge a strategic partnership aimed at developing groundbreaking remyelination…
Evogene Strengthens Leadership in AI-Driven Drug Discovery with New Appointment Evogene Ltd., a pioneer in computational chemistry focused on generative design for pharmaceuticals and agriculture, ann…
Evogene Strengthens Leadership with Appointing Dr. Olga Nissan as VP of Business Development Evogene Ltd., a prominent player in the realm of computational chemistry, announces the appointment of Dr.…
Evogene's Progress in Advancing Agricultural Biotechnology Evogene, a biotechnology company focused on improving agricultural productivity, continues to make strides in its mission to enhance crop yie…
Evogene's Upcoming Earnings Announcement Highlights Industry Trends in Biotechnology Evogene, a prominent player in the biotechnology and agricultural innovation sector, is poised to release its quart…
Evogene Set to Showcase Innovations in Sustainable Agriculture As Evogene prepares for its quarterly earnings announcement on November 20, 2025, the biotechnology firm's focus on agricultural innovati…
Evogene Highlights Strategic Focus on AI-Driven Innovations in Pharmaceuticals and Agriculture Evogene Ltd., a pioneering force in computational biology and chemistry, reaffirms its commitment to inno…
Evogene Emphasizes AI-Driven Innovations in Pharmaceutical and Agricultural Development Evogene Ltd., a frontrunner in computational biology and chemistry, showcases its commitment to advancing drug a…
Innovative Partnership Aims to Revolutionize Drug Discovery for Metabolic Diseases Evogene Ltd., a computational biology and chemistry firm based in Rehovot, Israel, embarks on a promising scientific…
Benzinga Pioneers AI Integration in Content Creation In a rapidly evolving media landscape, Benzinga stands out by integrating artificial intelligence (AI) tools into its content creation process. Thi…
AI-Powered Content Creation: A New Era for Media Evogene, a biotechnology company specializing in the development of innovative solutions for agriculture, is witnessing the transformative effects of a…
AI-Driven Content Creation: A New Era for Media and Technology In recent developments, the integration of artificial intelligence (AI) in content creation is revolutionizing industries, particularly i…